Suppr超能文献

移植过大尺寸不匹配肾移植术后C4d表达性肾小球病和蛋白尿:一例预后良好的罕见病例

C4d-expressing glomerulopathy and proteinuria post transplantation of a too-big-for-size mismatched kidney allograft: An unusual case with good outcome
.

作者信息

Gougeon Francois, Mikhailov Alexei V, Gibson Keisha, Kozlowski Tomasz, Singh Harsharan K, Nickeleit Volker

出版信息

Clin Nephrol. 2017 Dec;88(12):364-370. doi: 10.5414/CN109296.

Abstract

A 5-year-old severely growth-retarded child with tubulointerstitial, oliguric end-stage renal disease received an adult-size kidney transplant. Three years post grafting under standard triple immunosuppression (mycophenolate mofetil, tacrolimus, and prednisone) de novo nephrotic range proteinuria without the nephrotic syndrome developed. Graft function was normal (serum creatinine: 0.2 - 0.3 mg/dL), there were no donor-specific HLA antibodies (DSA), and the urine sediment was inactive. Two biopsies collected 3 and 4 years post-transplantation showed severe glomerular capillary wall remodeling and associated pseudolinear C4d staining as morphologic correlates for the proteinuria. Changes resembled those seen in so-called "size-mismatch transplant glomerulopathies". There was no evidence of a glomerulonephritis, acute or chronic rejection including transplant glomerulopathy, interstitial fibrosis, peritubular capillary C4d deposits, or multilamination of peritubular capillary basement membranes. The glomerular changes were not detected in the implantation zero-hour biopsy or the recipient's native renal biopsy. At the end of follow-up 64 months post transplantation, proteinuria persisted at subnephrotic levels in the setting of stable graft function and undetectable DSAs. This unique case adds to the list of causes of nonrejection-associated post-transplant proteinuria. It demonstrates for the first time that a too-large-for-body-size mismatched graft is associated with a presumably sheer stress-induced C4d expressing glomerulopathy, severe proteinuria, and favorable outcome.
.

摘要

一名患有肾小管间质、少尿型终末期肾病的5岁严重生长发育迟缓儿童接受了成人尺寸的肾脏移植。移植后3年,在标准三联免疫抑制(霉酚酸酯、他克莫司和泼尼松)治疗下,出现了无肾病综合征的新发肾病范围蛋白尿。移植肾功能正常(血清肌酐:0.2 - 0.3mg/dL),没有供体特异性HLA抗体(DSA),尿沉渣无异常。移植后3年和4年采集的两次活检显示严重的肾小球毛细血管壁重塑以及相关的假线性C4d染色,作为蛋白尿的形态学相关表现。这些变化类似于在所谓的“尺寸不匹配移植肾小球病”中所见。没有证据表明存在肾小球肾炎、急性或慢性排斥反应,包括移植肾小球病、间质纤维化、肾小管周围毛细血管C4d沉积或肾小管周围毛细血管基底膜多层化。在植入零时活检或受者的自体肾活检中未检测到肾小球变化。在移植后64个月的随访结束时,在移植肾功能稳定且未检测到DSA的情况下,蛋白尿持续处于亚肾病水平。这一独特病例增加了非排斥相关移植后蛋白尿的病因清单。它首次证明,对于身体尺寸而言过大的不匹配移植肾与可能纯粹由应力诱导的C4d表达性肾小球病、严重蛋白尿及良好预后相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验